Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Replicase polyprotein 1ab (HCoV-OC43) | BDBM476338![]() (US10874687, Compound 1B) | PDB UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (HCoV-OC43) | BDBM476339![]() (US10874687, Sofosbuvir) | PDB UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (HCoV-229E) | BDBM476338![]() (US10874687, Compound 1B) | PDB MMDB KEGG UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.50E+3 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (HCoV-229E) | BDBM476339![]() (US10874687, Sofosbuvir) | PDB MMDB KEGG UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (HCoV-OC43) | BDBM476337![]() (US10874687, Compound 1A) | PDB UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (HCoV-229E) | BDBM476339![]() (US10874687, Sofosbuvir) | PDB MMDB KEGG UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (HCoV-229E) | BDBM476337![]() (US10874687, Compound 1A) | PDB MMDB KEGG UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (HCoV-OC43) | BDBM476337![]() (US10874687, Compound 1A) | PDB UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (HCoV-OC43) | BDBM476338![]() (US10874687, Compound 1B) | PDB UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (HCoV-OC43) | BDBM476339![]() (US10874687, Sofosbuvir) | PDB UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (HCoV-229E) | BDBM476337![]() (US10874687, Compound 1A) | PDB MMDB KEGG UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Replicase polyprotein 1ab (HCoV-229E) | BDBM476338![]() (US10874687, Compound 1B) | PDB MMDB KEGG UniProtKB/SwissProt GoogleScholar | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.90E+3 | n/a | n/a | n/a | n/a |
Atea Pharmaceuticals, Inc. US Patent | Assay Description Compound activity against coronavirus was based on inhibition of virus induced cytopathogenicity acutely infected with a multiplicity of infection (m... | US Patent US10874687 (2020) | |||||||||||
More data for this Ligand-Target Pair |